Delta Sleep-Inducing Peptide (DSIP) is a nonapeptide (Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu) first isolated from cerebral venous blood and named for its early association with delta-wave electroencephalographic (EEG) activity. It is an unusual tool compound because, despite decades of study, its receptor and precise mechanism remain incompletely defined — which is exactly why it continues to appear in neuroendocrine and neurophysiology research.
Delta-EEG and Neurophysiology
The peptide's original characterization tied it to slow-wave EEG patterns in animal models. Subsequent research has examined its distribution across brain regions and peripheral tissue and its possible role as a modulator rather than a direct effector, a framing that keeps it relevant to studies of endogenous regulatory peptides.
Neuroendocrine and Stress-Axis Research
A substantial body of DSIP literature concerns the neuroendocrine system, including reported interactions with corticotropin and other stress-axis signaling in model systems, and effects on oxidative-stress markers. Because these findings are diffuse and mechanism-level questions remain open, DSIP is often used as a probe in exploratory neuroendocrine research rather than as a well-defined receptor ligand.
Research Applications
- Delta-EEG and slow-wave neurophysiology models
- Neuroendocrine and hypothalamic-pituitary-axis signaling research
- Oxidative-stress marker studies
- Endogenous regulatory-peptide distribution and stability research
References
- Graf MV, Kastin AJ. Delta-sleep-inducing peptide (DSIP): a review. Neurosci Biobehav Rev 1984. PMID: 6145137.
- Kovalzon VM, Strekalova TV. Delta sleep-inducing peptide (DSIP): a still unresolved riddle. J Neurochem 2006. PMID: 16539679.
This article summarizes publicly available research for educational purposes and does not constitute medical advice, a therapeutic claim, or a recommendation for human use. Products referenced are sold for laboratory research use only.